Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes.

Diamanti K, Visvanathar R, Pereira MJ, Cavalli M, Pan G, Kumar C, Skrtic S, Risérus U, Eriksson JW, Kullberg J, Komorowski J, Wadelius C, Ahlström H

Sci Rep 14 (1) 29632 [2024-11-28; online 2024-11-28]

PubMed 39609490

DOI 10.1038/s41598-024-78537-6

Crossref 10.1038/s41598-024-78537-6

pmc: PMC11604932
pii: 10.1038/s41598-024-78537-6